Shanghai HeartCare Medical Technology Corporation Limited researches, develops, manufactures, and sells neuro-interventional medical devices in Mainland China. Its product portfolio includes devices for acute ischemic stroke, such as thrombectomy stents, aspiration pumps, and aspiration catheters, as well as intracranial drug-eluting stents and balloon dilatation catheters for neurovascular stenosis. The company also offers embolic coils, intracranial stents, and flow diverters for hemorrhagic stroke, left atrial appendage occluders for ischemic stroke prevention, and peripheral interventional devices. Incorporated in 2016, it is headquartered in Shanghai, the People's Republic of China.